{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:47:09Z","timestamp":1789771629670,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.breast.2017.06.002","type":"journal-article","created":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T06:18:29Z","timestamp":1498198709000},"page":"48-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["A standard mastectomy should not be the only recommended breast surgical treatment for non-metastatic inflammatory breast cancer: A large population-based study in the Surveillance, Epidemiology, and End Results database 18"],"prefix":"10.1016","volume":"35","author":[{"given":"Hongliang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingdi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2017.06.002_bib1","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/cncr.22927","article-title":"Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease","volume":"110","author":"Cristofanilli","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2017.06.002_bib2","first-page":"351","article-title":"Inflammatory breast cancer: the disease, the biology, the treatment","volume":"60","author":"Robertson","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.breast.2017.06.002_bib3","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/cncr.25682","article-title":"Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: a large population-based study","volume":"117","author":"Dawood","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2017.06.002_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3233\/BD-2006-22108","article-title":"Surgical aspects of inflammatory breast cancer","volume":"22","author":"Kell","year":"2005","journal-title":"Breast Dis"},{"key":"10.1016\/j.breast.2017.06.002_bib5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/annonc\/mdq345","article-title":"International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment","volume":"22","author":"Dawood","year":"2011","journal-title":"Ann Oncol : Official Journal of the European Society for Medical Oncology\/ESMO"},{"key":"10.1016\/j.breast.2017.06.002_bib6","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/annonc\/mdu121","article-title":"Survival of women with inflammatory breast cancer: a large population-based study","volume":"25","author":"Dawood","year":"2014","journal-title":"Ann Oncol : Official Journal of the European Society for Medical Oncology"},{"key":"10.1016\/j.breast.2017.06.002_bib7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ijrobp.2012.01.030","article-title":"Modern outcomes of inflammatory breast cancer","volume":"84","author":"Rehman","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2017.06.002_bib8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1053\/j.seminoncol.2007.11.008","article-title":"Surgical management of inflammatory breast cancer","volume":"35","author":"Singletary","year":"2008","journal-title":"Semin Oncol"},{"key":"10.1016\/j.breast.2017.06.002_bib9","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/annonc\/mdr319","article-title":"Identifying factors that impact survival among women with inflammatory breast cancer","volume":"23","author":"Dawood","year":"2012","journal-title":"Ann Oncol : Official Journal of the European Society for Medical Oncology\/ESMO"},{"key":"10.1016\/j.breast.2017.06.002_bib10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/COC.0b013e318271b34b","article-title":"Initial response to chemotherapy, not delay in diagnosis, predicts overall survival in inflammatory breast cancer cases","volume":"37","author":"Hoffman","year":"2014","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.breast.2017.06.002_bib11","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/COC.0b013e3182937921","article-title":"Outcomes after multidisciplinary treatment of inflammatory breast cancer in the Era of neoadjuvant HER2-directed therapy","volume":"38","author":"Tsai","year":"2015","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.breast.2017.06.002_bib12","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1177\/000313481408001006","article-title":"Long-term follow-up of breast-conserving therapy in patients with inflammatory breast cancer treated with neoadjuvant chemotherapy","volume":"80","author":"Bonev","year":"2014","journal-title":"Am Surg"},{"key":"10.1016\/j.breast.2017.06.002_bib13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10549-016-4017-3","article-title":"Outcomes of patients with inflammatory breast cancer treated by breast-conserving surgery","volume":"160","author":"Brzezinska","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2017.06.002_bib14","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/bjc.2015.115","article-title":"Inflammatory breast cancer: time to standardise diagnosis assessment and management, and for the joining of forces to facilitate effective research","volume":"112","author":"Rea","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.breast.2017.06.002_bib15","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1200\/JCO.2007.12.3141","article-title":"Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment","volume":"25","author":"Tuttle","year":"2007","journal-title":"J\u00a0Clin Oncol : Official Journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.breast.2017.06.002_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2017.0115","article-title":"State variation in the receipt of a contralateral prophylactic mastectomy among women who received a diagnosis of invasive unilateral early-stage breast cancer in the United States, 2004\u20132012","author":"Nash","year":"2017","journal-title":"JAMA Surg"},{"key":"10.1016\/j.breast.2017.06.002_bib17","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1245\/s10434-016-5367-0","article-title":"Contralateral prophylactic mastectomy for women with T4 locally advanced breast cancer","volume":"23","author":"Murphy","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2017.06.002_bib18","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ejso.2011.12.014","article-title":"Increasing rates of contralateral prophylactic mastectomy - a trend made in USA?","volume":"38","author":"Guth","year":"2012","journal-title":"Eur J Surg Oncol : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology"},{"key":"10.1016\/j.breast.2017.06.002_bib19","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1245\/s10434-013-3108-1","article-title":"Operative risks associated with contralateral prophylactic mastectomy: a single institution experience","volume":"20","author":"Miller","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2017.06.002_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10549-010-1324-y","article-title":"Inflammatory breast cancer: high risk of contralateral breast cancer compared to comparably staged non-inflammatory breast cancer","volume":"129","author":"Schairer","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2017.06.002_bib21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.bjc.6605434","article-title":"Relation of risk of contralateral breast cancer to the interval since the first primary tumour","volume":"102","author":"Rubino","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.breast.2017.06.002_bib22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/COC.0b013e318292f8a7","article-title":"Decision making and factors influencing long-term satisfaction with prophylactic mastectomy in women with breast cancer","volume":"38","author":"Soran","year":"2015","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.breast.2017.06.002_bib23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1245\/s10434-015-4660-7","article-title":"Contralateral prophylactic mastectomy: factors predictive of occult malignancy or high-risk lesion and the impact of MRI and genetic testing","volume":"23","author":"Erdahl","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2017.06.002_bib24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.breast.2016.11.025","article-title":"Women's preferences for contralateral prophylactic mastectomy following unilateral breast cancer: what risk-reduction makes it worthwhile?","volume":"31","author":"Tesson","year":"2017","journal-title":"Breast (Edinburgh, Scotland)"},{"key":"10.1016\/j.breast.2017.06.002_bib25","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1001\/jamasurg.2016.4749","article-title":"Contralateral prophylactic mastectomy decisions in a population-based sample of patients with early-stage breast cancer","volume":"152","author":"Jagsi","year":"2017","journal-title":"JAMA Surg"},{"key":"10.1016\/j.breast.2017.06.002_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamasurg.2014.2895","article-title":"Nationwide trends in mastectomy for early-stage breast cancer","volume":"150","author":"Kummerow","year":"2015","journal-title":"JAMA Surg"},{"key":"10.1016\/j.breast.2017.06.002_bib27","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.surg.2015.11.001","article-title":"Use of immediate breast reconstruction and choice for contralateral prophylactic mastectomy","volume":"159","author":"Hoskin","year":"2016","journal-title":"Surgery"},{"key":"10.1016\/j.breast.2017.06.002_bib28","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10549-014-3160-y","article-title":"Contralateral prophylactic mastectomy and its association with reduced mortality: evidence for selection bias","volume":"148","author":"Jatoi","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2017.06.002_bib29","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1097\/SLA.0000000000000908","article-title":"Patient-reported quality of life and satisfaction with cosmetic outcomes after breast conservation and mastectomy with and without reconstruction: results of a survey of breast cancer survivors","volume":"261","author":"Jagsi","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.breast.2017.06.002_bib30","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1200\/JCO.2014.55.1978","article-title":"Underuse of trimodality treatment affects survival for patients with inflammatory breast cancer: an analysis of treatment and survival trends from the National Cancer Database","volume":"32","author":"Rueth","year":"2014","journal-title":"J\u00a0Clin Oncol : Official Journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.breast.2017.06.002_bib31","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S1072-7515(99)00267-7","article-title":"Esthetic reconstruction after mastectomy for inflammatory breast cancer: is it worthwhile?","volume":"190","author":"Chin","year":"2000","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.breast.2017.06.002_bib32","doi-asserted-by":"crossref","first-page":"262e","DOI":"10.1097\/PRS.0000000000000900","article-title":"Challenging a traditional paradigm: 12-year experience with autologous free flap breast reconstruction for inflammatory breast cancer","volume":"135","author":"Chang","year":"2015","journal-title":"Plastic Reconstr Surg"},{"key":"10.1016\/j.breast.2017.06.002_bib33","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1245\/s10434-016-5554-z","article-title":"Immediate reconstruction in inflammatory breast cancer: challenging current care","volume":"23","author":"Simpson","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2017.06.002_bib34","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1245\/ASO.2006.02.020","article-title":"The prognostic effect of the number of histologically examined axillary lymph nodes in breast cancer: stage migration or age association?","volume":"13","author":"Schaapveld","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2017.06.002_bib35","article-title":"Sentinel lymph node biopsy for patients with early-stage breast cancer: American society of clinical oncology clinical practice guideline update","author":"Lyman","year":"2016","journal-title":"J\u00a0Clin Oncol : Official Journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.breast.2017.06.002_bib36","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.clbc.2013.04.002","article-title":"Risk factors for locoregional failure in patients with inflammatory breast cancer treated with trimodality therapy","volume":"13","author":"Saigal","year":"2013","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.breast.2017.06.002_bib37","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijsu.2009.04.012","article-title":"Sentinel lymph node biopsy after neoadjuvant chemotherapy in inflammatory breast cancer","volume":"7","author":"Hidar","year":"2009","journal-title":"Int J Surg (London, England)"},{"key":"10.1016\/j.breast.2017.06.002_bib38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF02573060","article-title":"Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer","volume":"9","author":"Stearns","year":"2002","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2017.06.002_bib39","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2017.0562","article-title":"Identification of patients with documented pathologic complete response in the breast after neoadjuvant chemotherapy for omission of axillary surgery","author":"Tadros","year":"2017","journal-title":"JAMA Surg"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977617304630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977617304630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:37:36Z","timestamp":1760776656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977617304630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":39,"alternative-id":["S0960977617304630"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2017.06.002","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A standard mastectomy should not be the only recommended breast surgical treatment for non-metastatic inflammatory breast cancer: A large population-based study in the Surveillance, Epidemiology, and End Results database 18","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2017.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}